Skip to content
10-Q

Quarterly Report

AV THERAPEUTICS, INC.

0001185185-13-002524

← back to feed
Filed
Nov 18, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 15, 2013 84M sh
Capex Q3 2013 · Sep 30, 2013 $0
Capex Q3 2013 · Sep 30, 2013 $18K
Capex Q3 2013 · Sep 30, 2012 $13K
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$45.53K
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$31.23K
Stockholders Equity Q3 2013 · Sep 30, 2013 −$10.22K
Stockholders Equity Q3 2013 · Dec 31, 2012 $531
Stockholders Equity Q3 2013 · Dec 31, 2011 $16.4K
Stockholders Equity Q3 2013 · Dec 31, 2010 $0
Current Liabilities Q3 2013 · Sep 30, 2013 $10.29K
Current Liabilities Q3 2013 · Dec 31, 2012 $8.67K
Current Assets Q3 2013 · Sep 30, 2013 $74
Current Assets Q3 2013 · Dec 31, 2012 $4.2K
Total Assets Q3 2013 · Sep 30, 2013 $74
Total Assets Q3 2013 · Dec 31, 2012 $9.2K
Sga Expense Q3 2013 · Sep 30, 2013 $61.75K
Sga Expense Q3 2013 · Sep 30, 2012 $2.83K
Sga Expense Q3 2013 · Sep 30, 2012 $33.58K
Net Income Q3 2013 · Sep 30, 2013 −$66.62K
Net Income Q3 2013 · Dec 31, 2012 −$43.87K
Net Income Q3 2013 · Sep 30, 2012 −$15.83K
Net Income Q3 2013 · Sep 30, 2012 −$46.58K
Net Income Q3 2013 · Dec 31, 2011 −$1.6K
Operating Income Q3 2013 · Sep 30, 2013 −$53.77K
Operating Income Q3 2013 · Sep 30, 2012 −$2.83K
Operating Income Q3 2013 · Sep 30, 2012 −$33.58K
Revenue Q3 2013 · Sep 30, 2013 $7.98K
Revenue Q3 2013 · Sep 30, 2012 $0
Revenue Q3 2013 · Sep 30, 2012 $0
Cash And Equivalents Q3 2013 · Sep 30, 2012 $1.59K
Cash And Equivalents Q3 2013 · Dec 31, 2011 $17.83K
Cash And Equivalents Q3 2013 · Nov 13, 2011 $0